USPSTF guidelines puts men in danger

USPSTF guidelines puts men in danger

The U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.

Read More

Statin & metformin combination reduces prostate cancer death risk

Statin & metformin combination reduces prostate cancer death risk

A new study from suggests that statins either alone or in combination with metformin may reduce the risk of dying from prostate cancer. The study’s findings were presented at the American Society of Clinical Oncology annual meeting in Chicago. The study was carried out by Grace L. Lu-Yao, PhD, an epidemiologist at the Rutgers Cancer Institute of New Jersey in New Brunswick.

Read More